CASE REPORT
Year : 2019 | Volume
: 24 | Issue : 1 | Page : 60--62
Memantine as an augmentation therapy in obsessive–Compulsive disorder
Parul Gupta, Shazia Anjum, Leezu Bhusri, Angad Harshbir Singh
Department of Psychiatry, Maharishi Markandeshwar Institute of Medical Sciences and Research, Ambala, Haryana, India
Correspondence Address:
Shazia Anjum
Block-H Flat No. 11 MMU, Mullana, Ambala - 133 207, Haryana
India
Obsessive Compulsive Disorders a mental illness, which is long lasting and the person has recurrent thoughts or mental images and compulsive acts, which the person is unable to resist. SSRI and TCA are primarily used drugs for obsessive-compulsive disorder (OCD), but in few patients these lead to less response and some other augmenting drugs have to be added along with them. A role for glutamatergic dysfunction in the pathophysiology of OCD has been found. We report 2 cases with a diagnosis of OCD where the patients did not show good response on YBOCS with SSRI and other adjunctive drugs like venlafaxine, resperidone in adequate dose and duration. When memantine was added (20 mg) the patient showed improvement on YBOCS where score reduced within the 6 weeks of augmentation.
How to cite this article:
Gupta P, Anjum S, Bhusri L, Singh AH. Memantine as an augmentation therapy in obsessive–Compulsive disorder.J Mental Health Hum Behav 2019;24:60-62
|
How to cite this URL:
Gupta P, Anjum S, Bhusri L, Singh AH. Memantine as an augmentation therapy in obsessive–Compulsive disorder. J Mental Health Hum Behav [serial online] 2019 [cited 2023 Jun 6 ];24:60-62
Available from: https://www.jmhhb.org/article.asp?issn=0971-8990;year=2019;volume=24;issue=1;spage=60;epage=62;aulast=Gupta;type=0 |
|
|
|
